More Growth Near Charlotte: Eli Lilly Moves Forward With $77M Concord Project

Eli Lilly secures $77M permit for Concord expansion

Eli Lilly and Co. has received a $77 million building permit for additional manufacturing work at its Concord campus, supporting installation of a new injectable-medicine production line. The expansion adds to Lilly’s more than $2 billion investment at The Grounds, where about 600 employees manufacture diabetes and obesity treatments.

More Growth Near Charlotte: Eli Lilly Moves Forward With $77M Concord Project

Eli Lilly just pulled a $77 million building permit for its Concord campus, signaling the next major step in a local expansion that’s tied to the drugmaker’s $50+ billion U.S. manufacturing push. The project includes a new manufacturing line being built by McFarland Construction. The latest permit focuses on interior upgrades and equipment installation inside an existing building. The work supports injectable production and packaging, continuing…